Internal Server Error

CorWave - About the company

CorWave is a series C company based in Clichy (France), founded in 2012. It operates as a Developer of implantable heart assist pumps for advanced heart failure. CorWave has raised $92.8M in funding from investors like Europa, Ysios Capital and Bpifrance. The company has 103 active competitors, including 57 funded and 13 that have exited. Its top competitors include companies like CVRx, Impulse Dynamics and Element Science.

Company Details

Developer of implantable heart assist pumps for advanced heart failure. These medical devices utilize wave membrane technology to provide pulsatile blood flow for patients suffering from cardiac conditions. The technology functions as a left ventricular assist device to support heart function.
Social
X
Email ID
*****@corwave.com
Phone Number
+33 **********
Key Metrics
Founded Year
2012
Location
Clichy, France
Stage
Series C
Total Funding
$92.8M in 7 rounds
Latest Funding Round
Investors
Ranked
Annual Revenue
€10M - €50M as on Dec 31, 2023
Employee Count
128 as on Sep 30, 2026
Similar Companies
Sign up to download CorWave's company profile

CorWave's funding and investors

CorWave has raised a total funding of $92.8M over 7 rounds. Its first funding round was on 2013. Its latest funding round was a Series C round on Jun 20, 2023 for $*****. 3 investors participated in its latest round. CorWave has 15 institutional investors.

Here is the list of recent funding rounds of CorWave:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jun 20, 2023
5354920
Series C
7419755
5686770
9283901
5397031
Jan 06, 2021
4764518
Series C
3838417
7461615
7752904
Oct 01, 2020
1820333
Grant (prize money)
8307634
6162336
7189565
lockAccess funding benchmarks and valuations. Sign up today!

CorWave's founders and board of directors

Founder? Claim Profile

CorWave's employee count trend

CorWave has 128 employees as of Sep 26. Here is CorWave's employee count trend over the years:
Employee count trend for CorWave
lockUncover CorWave's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

CorWave's Competitors and alternates

Top competitors of CorWave include CVRx, Impulse Dynamics and Element Science. Here is the list of Top 10 competitors of CorWave, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for CVRx
CVRx
2001, Minneapolis (United States), Public
Developer of implantable technology for hypertension and heart failure
$394M
68/100
2nd
Logo for Impulse Dynamics
Impulse Dynamics
1998, Marlton (United States), Series F
Provider of implantable device for treatment of chronic heart failure
$685M
64/100
3rd
Logo for CorWave
CorWave
2012, Clichy (France), Series C
Developer of implantable heart assist pumps for advanced heart failure
$92.8M
63/100
4th
Logo for Element Science
Element Science
2013, San Francisco (United States), Series C
Wearable therapeutic device for treating sudden cardiac arrest
$193M
61/100
5th
Logo for SynCardia
SynCardia
2001, Tucson (United States), Public
Artificial heart
$72M
60/100
6th
Logo for FineHeart
FineHeart
2010, Pessac (France), Series C
Manufacturer of implantable medical devices for treating advanced heart failure
$51.9M
57/100
7th
Logo for Restore Medical
Restore Medical
2016, Tel Aviv (Israel), Series B
Catheter-delivered implant for treatment of congestive heart failure
$32M
57/100
8th
Logo for Procyrion
Procyrion
2005, Houston (United States), Series E
Developer of percutaneous mechanical circulatory support devices for heart failure
$114M
56/100
9th
Logo for Berlin Heals
Berlin Heals
2010, Zug (Switzerland), Series B
Developer of a microcurrent device for heart failure treatment. This device is a novel cardiac implant that provides a minimal electrical direct current to the heart, promoting reverse remodeling of cardiac muscle tissue. The treatment has shown rapid improvements in heart function, size, and quality of life in clinical studies. The device is easily implantable and requires no additional medication or follow-up procedures. The company is currently conducting clinical studies to obtain regulatory approvals.
$34.6M
51/100
10th
Logo for V-Wave
V-Wave
2009, Caesarea (Israel), Acquired
Provider of implantable shunt to treat heart failure
$132M
48/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on CorWave's competitors? Click here to see the top ones

CorWave's Investments and acquisitions

CorWave has made no investments or acquisitions yet.

Reports related to CorWave

Here is the latest report on CorWave's sector:

News related to CorWave

lockFilter this list
Media has covered CorWave for a total of 2 events in the last 1 year, 1 of them has been about people movement.
•
CorWave Strengthens its Leadership Team With Two Key Appointments Medical Product Outsourcing•Jun 09, 2026•CorWave
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about CorWave

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford